Typhoid Vaccine Recalled

An estimated 700,000 people immunized against typhoid may not be fully protected.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Salmonella enterica (serovar typhimurium)Centers for Disease Control and PreventionThe typhoid vaccine called Typhim Vi made by Sanofi Pasteur was recalled this week (October 8), due to insufficient potency in 88 percent of its stock. Anyone immunized after January 2011 could have received the weaker vaccine that may not protect against infection, reported BBC News.

Typhoid fever, in which patients can experience sustained temperatures of 103 degrees Fahrenheit or higher, as well as stomach pains and rose-colored spots, is caused by the bacterium Salmonella Typhi. The disease is not common in the United Kingdom or the United States, but it still causes 21 million infections per year in the developing world. Visitors to South or South East Asia commonly get the vaccine prior to travel, and the U.K.’s Medicines and Healthcare products Regulatory Agency said that travelers returning from those areas should be vigilant for signs of disease, and contact a doctor immediately if symptoms appear.

"There are no concerns over the safety of this vaccine, but the recall has taken place because the vaccine may not be as effective ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Edyta Zielinska

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo